Bullish & Foolish
--
--

Is Sintx Technologies going out of business?

Loading the full analysis
Reading the filings

Sintx Technologies, Inc. (SINT) Fundamentals

A quick summary of the latest filed figures while the full analysis loads.

Sintx Technologies, Inc. (SINT) scores 8 out of 100 on fundamentals, Distressed / Caution, based on SEC filing data.

Quality score 8/100
Rating Distressed / Caution
Sector Biotech/Pharma
Market cap $10.9M
Last close $1.63
Revenue growth (YoY) -64.7%
FCF margin (TTM) -860.1%
Dividend yield 0.0%

Leading signal: Shares dilution YoY: 105.65% (YoY)

Five questions, kept separate

Survival - Critical
4-6 mo of estimated runway from 2026-06-30, based on $3.6M of cash and short-term investments against $8.8M of annual burn. A disclosed filing event caps this reading; Event Risk carries the detail.
Business quality - Pre-commercial
Operating margins cannot grade a pipeline; Survival and clinical evidence remain the relevant lenses here.
Trajectory - Clinical progress unavailable
Fundamentals can show funding and burn, but not whether the clinical pipeline is advancing.
Valuation - Extreme expectations
-19.6% net-cash backing support an extreme expectations pre-commercial Valuation assessment.
Event risk - Critical event risk
Going-Concern Warning is the decisive filing event; one adverse event family is active. It appears across 2 scanned filings. Favorable events are shown separately and do not offset adverse risk.

What the rules read

  • Shares dilution YoY: 105.65% (YoY)
  • ROIC: -311.79%
  • Filing event risk: Going-Concern Warning (-8 pts)
  • Cash Runway (years): 0.41y
  • Revenue CAGR (3Y): -13.28%
  • Debt / Equity: No financial debt (debt-free)
  • Return on Assets: -99.37%
  • Revenue growth YoY: 199.34% (YoY) - Early-Stage Surge (low base)
  • FCF margin: -860.12% (Inv. Mode)
  • Cash Burn Deceleration: -80.02% QoQ improvement (Worsening)
  • Working Capital Efficiency: 44.48x (Well-funded)
  • Debt Maturity Runway: 0% long-term (Near-term refinancing risk)

Read from filings through 2026-08-13.

Price as of 2026-09-07.

Headline score detail

Source coverage and limitations
--
Reference Links